Home > Press > Enable IPC Ultracapacitor Tests Exceed Performance Target
Enable IPC Corporation (OTCBB: EIPC) today announced that initial test results of its ultracapacitor technology showed a substantial performance improvement over their target specification, which was derived from the published data of similar commercially-available devices.
Enable IPC Ultracapacitor Tests Exceed Performance Target
VALENCIA, CA | Posted on July 30th, 2007
The ultracapacitor technology, which originated at the University of Wisconsin (UW), is being researched under a multi-phased, milestone-based joint development program between Enable IPC and SolRayo, LLC- a firm consisting of the UW researchers who invented the technology.
"When we went into this, we felt the primary advantage would be manufacturing costs," said Dr. Mark
Daugherty, Chief Technology Officer of Enable IPC. "It now appears that there may be a significant
improvement in actual capacitor performance as well."
Kevin Leonard, CEO of SolRayo and one of the inventors of the technology, said, "We have exceeded our target specification of 3,000 farads per liter by a significant margin for comparably-sized, low-capacitance, lower priced ultracapacitors, which are used primarily in consumer electronics."
The ultracapacitor technology involves common types of carbon sheets with deposited nanoparticles -
material that is thousands of times thinner than a human hair - that results in a significant improvement in surface area and manufacturing costs.
The second of four development phases in the program is close to completion. In this phase, researchers examined and tested various types of carbon and deposition methods.
Although the results have been significantly better than what researchers initially expected, they noted that the testing involved unpackaged containers that do not reflect the final product packaging.
"These results are exciting, but also preliminary," Dr. Daugherty cautioned. "The real results will not be known until we are able to actually package the devices in commercially-usable designs and conduct full testing under a variety of conditions."
About Enable IPC Corporation
Enable IPC Corporation is developing power devices using advances in thin films and nanotechnology. Our products include microbatteries for very low power applications (utilizing nanowires as small as 1/1000th the diameter of a human hair) and ultracapacitors for a wide range of uses (utilizing nanoparticles on carbon). The microbattery is targeted for use in healthcare products, RFID tags, smart cards and many other applications while the ultracapacitor is to be used in consumer electronics.
This release contains forward-looking statements, such as "believes," "expected," “appears”, "targeted" and similar terminology, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties which could cause actual results that the Company achieves to differ materially from any of the forward-looking statements. Such risks and uncertainties, include, but are not limited to, the following: the timely
development and market acceptance of products and technologies, the ability to secure additional sources of financing, the difficulties in forecasting results from development efforts, difficulties in accurately estimating market growth, the impact of changing economic conditions, business conditions in the
microbattery industry and others identified in our Annual Report on Form 10-KSB, as amended, and other Securities and Exchange Commission filings. The company undertakes no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
For more information, please click here
Enable IPC Corporation
Rich Kaiser, 800-631-8127 (Investor Relations)
Copyright © Enable IPC Corporation
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Promising use of nanodiamonds in delivering cancer drug to kill cancer stem cells: NUS study shows that delivery of Epirubicin by nanodiamonds resulted in a normally lethal dosage of Epirubicin becoming a safe and effective dosage for treatment of liver cancer January 26th, 2015
GS7 Graphene Sensor maybe Solution in Fight Against Cancer January 25th, 2015
NANOPOSTER 2015 - 5th Virtual Nanotechnology Conference - call for abstracts January 24th, 2015
Nanosensor Used for Simultaneous Determination of Effective Tea Components January 24th, 2015
Battery Technology/Capacitors/Generators/Piezoelectrics/Thermoelectrics/Energy storage
Toyocolor to Launch New Carbon Nanotube Materials at nano tech 2015 January 24th, 2015
Smart keyboard cleans and powers itself -- and can tell who you are January 21st, 2015
Presence of Nanoparticles in Efforts to Boost Lifetime of Super Capacitors January 20th, 2015
Carbon nanotube finding could lead to flexible electronics with longer battery life January 14th, 2015